First disease-specific data module in neuroscience, Qdata™ SMA, helps power exclusive real-world evidence generation into a rare-disease patient journey from one of world's largest clinical...

Final results from long-term, open-label, repeat-dose Phase 3 study of VALTOCO® (diazepam nasal spray) for episodes of frequent seizure activity include findings on ease of dosing and quality of life

Production Deployments of 56G PAM4 Signaling Growing Significantly for Hyperscale Server Interconnects SANTA CLARA, Calif., April 4, 2022 /PRNewswire/ -- (TSXV:SEV) (OTCQB:SPVNF) Spectra7...

Amesite Inc. (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform and content creation services for business, university, non-profit, and...

- ETESIAN Phase 2b study of ION449 (AZD8233) met its primary and secondary endpoints; ION449 was generally well tolerated - ION449 demonstrated potential best-in-class efficacy profile for a...